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ABSTRACT: The synthetic modification of proteins plays an
important role in chemical biology and biomaterials science.
These fields provide a constant need for chemical tools that
can introduce new functionality in specific locations on protein
surfaces. In this work, an oxidative strategy is demonstrated for
the efficient modification of N-terminal residues on peptides
and N-terminal proline residues on proteins. The strategy uses
o-aminophenols or o-catechols that are oxidized to active coupling species in situ using potassium ferricyanide. Peptide screening
results have revealed that many N-terminal amino acids can participate in this reaction, and that proline residues are particularly
reactive. When applied to protein substrates, the reaction shows a stronger requirement for the proline group. Key advantages of
the reaction include its fast second-order kinetics and ability to achieve site-selective modification in a single step using low
concentrations of reagent. Although free cysteines are also modified by the coupling reaction, they can be protected through
disulfide formation and then liberated after N-terminal coupling is complete. This allows access to doubly functionalized
bioconjugates that can be difficult to access using other methods.
■ INTRODUCTION
The synthetic modification of proteins enables the construction
of biomolecular hybrids that can be used to study protein
function,1 deliver potent therapeutics to cellular targets,2 and
build new materials.3 The synthesis of these constructs requires
a suite of chemoselective bioconjugation reactions that proceed
under mild, aqueous conditions in the presence of the native
functional groups that are present on protein surfaces.4−6 The
most common methods for protein modification target the
nucleophilic side-chains of lysine and cysteine.4,7,8 However,
these strategies can result in complex product mixtures, as
lysine is typically found in high abundance on the protein
surface9 and uniquely reactive cysteine labeling sites can be
difficult to install in many instances (such as thiol proteases and
proteins produced via the eukaryotic secretory pathway, for
example).
Many newer approaches for the site-selective modification of
proteins involve the introduction of artificial amino acids with
reactivities that are orthogonal10 to those of the native amino
acids. Along these lines, a number of powerful methods have
been developed for the selective modification of azide,11−17
alkyne,13−16 alkene,18−21 carbonyl,22,23 and aniline24−27 moi-
eties. However, the difficulty of introducing a non-canonical
amino acid can limit the application of these methods.
Complementary approaches rely on the site-selective mod-
ification of native amino acids by enzymes.28−33 In addition, a
reliable method for the modification of C-terminal thioesters
with N-terminal cysteines, termed “native chemical ligation”,
has been developed by Kent and co-workers.34,35 This method
has been used for the semi- and total synthesis of complex
protein substrates,36−38 including the chemical synthesis of a
single glycoform of human erythropoietin.39,40
As an alternative strategy, we and others have developed
methods for the selective modification of the N-terminal amino
group.41−50 Methods that target the N-terminus can offer
significant advantages for bioconjugate preparation, as they can
be used for a wide range of protein targets produced by virtually
any expression system. Conceptually powerful as they are,
however, these methods can be hampered by long reaction
times, often require large excesses of reagent, and/or involve at
least two-steps for the attachment of synthetic molecules. We
have therefore sought to develop new techniques that can
achieve N-terminal modification with similarly high positional
selectivity, but with significantly improved efficiency.
Herein, we report an oxidative coupling pathway that can
preferentially modify the N-terminus of proteins with fast
kinetics. Peptide substrates were first used to screen reaction
conditions and identify the site of modification. A peptide panel
with varying N-terminal residues was then evaluated to
determine the sequence specificity of the reaction, leading to
the identification of proline as the optimal N-terminal amino
acid. The reaction was next applied to protein substrates,
showing similarly high levels of conversion when an N-terminal
proline residue was present. This mild bioconjugation reaction
enables the facile, rapid modification of proteins to create a
well-defined and stable linkage in a single position, and thus
should be useful for many different applications in chemical
biology and the construction of biomolecular materials.
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■ RESULTS AND DISCUSSION
We have previously reported the chemoselective coupling of
aniline moieties on proteins to electron-rich aromatic rings,
such as o-aminophenols, at slightly acidic pH (6.0−6.5).25
These reactions require the addition of NaIO4
25 or K3Fe-
(CN)6
26 as a terminal oxidant, with the latter reagent exhibiting
improved compatibility with glycoproteins and substrates with
free sulfhydryl groups. The use of ferricyanide as the oxidant
also yields a single reaction product (1), whereas periodate
leads to the formation of a ring contracted species as a
competing pathway.25 The ferricyanide-based reactions are
presumed to involve an o-iminoquinone as the reactive
intermediate, as suggested in Scheme 1, or could involve the
corresponding o-quinone after imine hydrolysis. Taken
together, the oxidative coupling strategies have demonstrated
excellent functional group compatibility and the ability to join
large unprotected biomolecules at low concentrations, as
demonstrated for the coupling of peptides, polymers, and
nucleic acids to specific locations on viral capsids25,26,51 and
antibody Fc domains.27
While these coupling reactions were found to be highly
aniline-selective under the conditions used, several studies have
reported the reaction of o-aminophenols and o-catechols with
native amino acids, dating back to 1949.52−57 In addition,
recent work by Messersmith has shown the ability of proteins
to be coupled to o-quinone moieties present on polydopamine-
coated surfaces.58,59 These reports suggested that secondary
coupling pathways could be developed to achieve the
modification of native amino acids with o-aminophenols
(Scheme 1), and thus initial experiments were designed to
identify the optimal reaction conditions for achieving this with
complex molecules.
Screening Reactivity on Peptide Substrates. In our
previous work, we noted that low amounts of background
reactivity could be observed in aniline-based oxidative coupling
reactions when higher pH conditions (>pH 6.5) were used.26
In an initial effort to characterize this alternative reaction
pathway, conditions and reaction times were first screened to
increase the reaction yields for peptides that did not contain
aniline groups. Angiotensin I and melittin were used as
substrates, as they contain many reactive amino acids, including
Lys, Arg, His, Trp, and Tyr. The peptides were exposed to 2-
amino-p-cresol using K3Fe(CN)6 as the oxidant. The reaction
pH was varied from 5.5 to 8.5, and the reaction mixtures were
analyzed using MALDI-TOF MS (Supporting Information
Figure S1). The level of modification increased with the basicity
of the reaction, with near quantitative modification of
angiotensin I after 20 min at pH 7.5 and higher. Throughout
these initial investigations, it was noted that angiotensin and
melittin showed significant differences in reactivity, with
angiotensin consistently demonstrating better conversion.
MS/MS analysis of the angiotensin product was used to
identify the participating residue, and revealed that the N-
terminal amino group was responsible for the observed
reactivity (Supporting Information Figure S2). As further
confirmation of the site-selectivity, several peptide substrates
were screened for reactivity (Figure 1a and Supporting
Information Figure S3). Consistent with the N-terminal
reaction selectivity, the only peptide that did not react had a
pyroglutamate in this position, and therefore no free amino
group.
Scheme 1. Oxidative Coupling with o-Aminophenols
Figure 1. Peptide modification with o-aminophenols. (a) Modification
of commercially available peptides was monitored by MALDI-TOF
MS. The product can be observed at [M + 120] m/z. (b) A positional
scan of the N-terminal amino acid was evaluated. Peptides with the
sequence XADSWAG were tested for reactivity with 2-amino-p-cresol.
The reactions were run with 100 μM peptide, 200 μM aminophenol,
and 5 mM ferricyanide at pH 7.5 and analyzed by LC−MS. Shown is
the average percent modification with error bars representing the
standard deviation of three reactions. The same peptides were used for
a screen of coupling partner equivalents (c) and a time screen (d).
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The oxidative coupling conditions were next optimized using
the peptide substrates. Several buffer salts were screened for
compatibility with the reaction. Most buffers did not alter the
reactivity, but imidazole and buffers containing a morpholine or
piperazine ring (PIPES, HEPES, HEPPS, and MOPS)
significantly impeded the reaction (Supporting Information
Figure S4). This is possibly due to small amounts of buffer
impurities that react competitively with the oxidized
intermediate. The time course of the reaction was also
investigated (Supporting Information Figure S5). The reaction
reached its maximum conversion after only 20 min. In addition,
it was found that the peptides could be modified using NaIO4
as the oxidant, or 4-methylcatechol as the coupling partner
(Supporting Information Figures S6−7). Both of these
reactions showed the same dependence on pH; however,
moderate levels of modification were still observed at acidic pH
(5.5−6.5) when using these alternative coupling conditions.
These observations suggested that the peptides were reacting
with the o-quinone intermediate formed in situ from either the
catechol or the iminoquinone precursor (after imine hydrol-
ysis). The effect of the N-terminal residue on reactivity was
next investigated.
Screening N-Terminal Residues. Given the differential
reactivity observed on peptide substrates, we synthesized
peptides with varied N-terminal residues (XADSWAG) to
determine the specificity of the reaction. The base sequence
was selected to increase the mass of the peptide, impart water
solubility, and include a tryptophan residue for quantitation
using UV monitoring. The peptides were synthesized on the
solid phase using standard Fmoc synthesis, cleaved from the
resin, and purified by HPLC. After purification, the peptides
were resuspended in phosphate buffer, pH 7.5, adjusted to a
concentration of 1 mM, and stored at −20 °C until use. To
assess the effect of the N-terminal residue on reactivity, the
peptides (100 μM) were reacted with 2 equiv of 2-amino-p-
cresol (200 μM) in the presence of K3Fe(CN)6 (5 mM) in
phosphate buffer, pH 7.5 (Figure 1b). The reactions were
performed in triplicate and the modification was monitored by
LC−MS (see Supporting Information Figure S8 for represen-
tative MS data for the modified peptides). Most N-terminal
amino acids showed good-to-high levels of conversion (60−
90%), but proline stood out as the only residue that showed
nearly complete modification (90−100%). A second observa-
tion of this screen was the fact that tryptophan, tyrosine, and
methionine residues were not oxidized by the ferricyanide
reagent, consistent with our previous report of oxidative
coupling with this oxidant (see Supporting Information Figure
S8). However, free cysteine residues can be oxidized to various
species, potentially including disulfides and sulfenic acids, and
thus it is recommended that they be protected as disulfides
before oxidative coupling is attempted (vide inf ra).
To optimize the reagent ratios (specifically the equivalents of
o-aminophenol), the peptides (100 μM) were reacted with 1−
10 equiv of the o-aminophenol (100−1000 μM) in the
presence of ferricyanide (10 mM). After 30 min, the reactions
were quenched with excess tris(2-carboxyethyl)phosphine
(TCEP). It was demonstrated that conversion was highest
using 2−5 equiv of the coupling partner (Figure 1c). Using
more than 5 equiv of the aminophenol resulted in lower levels
of peptide modification. This was most likely due to the ability
of the aminophenol to react with itself at higher concentrations
(∼1 mM). Consistent with this, when using 10 equiv of the o-
aminophenol, a byproduct was observed with a mass that
corresponded to the condensation of 3 aminophenols (344
Da).
We also investigated the differences in coupling rates for
representative N-termini. The reaction of 2-amino-p-cresol with
three different peptides was monitored over the course of 1 h
(Figure 1d). The peptides (100 μM) were reacted with 2 equiv
of the o-aminophenol (200 μM) in the presence of ferricyanide
(5 mM), and aliquots were quenched with excess TCEP at the
indicated time points. The proline terminal peptide not only
reached the highest level of conversion, but also did so in a
significantly shorter time than the other termini. Despite efforts
to optimize conditions for all N-termini, proline still stood out
as the most reactive species.
Product Characterization with Small Molecule Ana-
logues. The reaction of N-terminal amines with o-amino-
phenols was characterized using small molecule mimics. The
methyl esters of phenylalanine (H-Phe-OMe) and proline (H-
Pro-OMe) were coupled to 2-amino-p-cresol using ferricyanide
at pH 7.5. The crude products were characterized using two-
dimensional NMR and high-resolution mass spectrometry. The
primary amine of H-Phe-OMe formed p-iminoquinone product
2, which was analogous to the one formed with aniline coupling
partners (Scheme 1, Supporting Information Figure S9).
However, the secondary amine of proline prevented the
formation of the p-iminoquinone tautomer, and thus favored
o-quinone product 3 (Scheme 1, Supporting Information
Figure S10). Given the different linkage obtained with proline,
we verified the stability of the product to a variety of conditions.
The proline terminal peptide, PADSWAG, was first modified
with 2-amino-p-cresol. After purification, the modified peptide
(100 μM) was exposed to reductants, nucleophiles and acidic
and basic pH (10 mM additives or buffer). After 8−18 h of
treatment, the peptides were analyzed by LC−MS. No loss of
product was observed under any of the conditions tested,
demonstrating the hydrolytic stability of the product
(Supporting Information Figure S11). The ability of the
linkage to withstand these conditions renders this method quite
useful for the construction of biomolecular materials for a
variety of applications. With a view toward in vivo applications,
current efforts are examining the stability of the linkage in
blood plasma, as well as evaluating the intrinsic immunogenicity
of the o-quinone group.
In the process of characterizing the reaction products, it was
observed that the colored products absorbed light at wave-
lengths greater than 500 nm (with λmax between 505 and 525
nm depending on the amine coupling partner). As the starting
coupling partners and ferricyanide did not absorb at these
wavelengths, this unique absorbance provided a means to
monitor the reaction progress. The different amine coupling
partners (p-toluidine, H-Pro-OMe, and H-Phe-OMe) were
reacted with 4-methylcatechol in the presence of 10 mM
ferricyanide, and the absorbance of the resulting solution was
monitored at 520 nm to determine the relative rates of
reactivity (Figure 2a; for unnormalized data see Supporting
Information Figure S12). The catechol substrate was used for
these studies to simplify the reaction pathway by eliminating
the imine hydrolysis step. The reactions were run under
pseudo-first order conditions with 0.1 mM catechol and 1 mM
amine coupling partner. When the reaction was carried out at
pH 6.0, only the aniline coupling partner exhibited rapid
coupling with the catechol. However, at pH 7.5 all three amines
reacted efficiently. The aniline coupling partner demonstrated
the fastest coupling (<30 s). The reaction with the proline
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analogue reached completion nearly as rapidly (∼2 min), but
the reaction with the primary aliphatic amine of phenylalanine
required longer reaction times (∼10 min). This demonstrates
how the reaction can have very high selectivity for aniline
residues.
By quantifying product formation by absorbance, we were
also able to measure the second-order rate constant for the
proline-based coupling (Supporting Information Figure S13).
The reaction of 1 equiv of H-Pro-OMe (100 μM) with 1 equiv
of 4-methylcatechol (100 μM) and 100 equiv of K3Fe(CN)6
(10 mM) was performed in triplicate at 25 °C. The second-
order rate constant for the coupling was determined to be 44 ±
4 M−1 s−1. While proline reacted rapidly with the electron-rich
coupling partner, the small molecule studies indicated that
aniline should react faster. The rate for the aniline reaction was
too fast under these conditions to determine the second-order
rate constant accurately.
Preferential Reactivity on Anilines over N-Terminal
Amines. Given the differences in reactivity observed at pH 6.0
and 7.5, we hypothesized that it would be possible to modify
the aniline side chain of p-aminophenylalanine (pAF) and the
N-terminal proline amine sequentially. To test this hypothesis,
we synthesized a peptide containing both reactive moieties
(PAD(pAF)SWAG). Only one modification was observed
when the peptide was reacted with 2-amino-p-cresol at pH 6.0
(Figure 2b). MS/MS analysis of the modified peptide
confirmed that the single modification occurred on the aniline
side chain (Supporting Information Figure S14). After this step,
the peptide was purified and subsequently reacted with 2-
amino-p-cresol at pH 7.5. Reaction at the higher pH enabled a
second modification of the peptide substrate, at the N-terminal
proline residue.
The preferential reactivity with aniline side chains was also
probed using protein substrates. The differential reactivity was
investigated by comparing the reactivity of a protein containing
a pAF residue to proteins without the artificial amino acid. The
pAF residue was introduced into the coat protein of
bacteriophage MS2, which self-assembles into a spherical,
hollow protein shell. Myoglobin and a mutant of the tobacco
mosaic virus (TMV) coat protein were used as native protein
substrates. Reactions with 2-amino-p-cresol were either
performed on the isolated, individual proteins or with the
aniline containing protein mixed with the native protein
substrate (Supporting Information Figure S15). Addition of
the aniline containing protein to the native protein decreased
the N-terminal reactivity, indicating that the aniline residues
react more rapidly than N-terminal residues with the o-
aminophenols. In addition, MS2 showed significantly higher
reactivity at all of the pHs tested, confirming preference for
aniline residues.
Application of N-Terminal Oxidative Coupling to
Proteins. The oxidative coupling reaction with N-terminal
amino groups was first tested on proteins with native N-
termini. Several proteins were reacted with o-aminophenol-
functionalized 5 kDa PEG under the optimized reaction
conditions (Figure 3). The native proteins showed moderate
levels of reactivity, which could be attributed to inaccessible N-
termini or simply to the less reactive N-terminal residues. To
test if proline terminal proteins were more reactive, a proline
residue was introduced to the N-terminus of GFP and the
tobacco mosaic virus (TMV) coat protein. The N-terminus of
TMV was also slightly extended from the native sequence
(addition of PAG). The proline-GFP was treated with a variety
of conditions to determine the specificity of the reaction
(Figure 4a). Only at basic pH in the presence of both the o-
aminophenol substrate and the oxidant was modification
observed. Additionally, the proline-terminal variant showed
significantly improved reactivity compared to that of the wild-
type N-terminus. These high levels of modification were
maintained even when only 1−2 equiv of the o-aminophenol
Figure 2. Characterization of the oxidative coupling reactions using
small molecules. (a) Amine coupling partners were reacted with 4-
methylcatechol as a model substrate. The reaction was followed by
monitoring the product absorbance at 520 nm. Reactions were run
under pseudo-first order conditions with 100 μM catechol, 1 mM
amine, 10 mM ferricyanide in 50 mM phosphate buffer. (b) A peptide
containing both an N-terminal proline and a p-aminophenylalanine
residue (PAD(pAF)SWAG) was tested for reactivity with 2 equiv of 2-
amino-p-cresol at pH 6. An aliquot of the reaction was quenched and
analyzed by LC−MS. The remainder of the reaction was purified and
then reacted with 2 equiv of the aminophenol at pH 7.5 and analyzed
by LC−MS.
Figure 3. Protein modification with o-aminophenols. (a) The N-
terminus of several proteins was PEGylated using o-aminophenol-
functionalized 5 kDa PEG and ferricyanide. (b) Modification of wild
type proteins with 5 kDa o-aminophenol-PEG was monitored by SDS-
PAGE. The products appear as higher MW bands in the lanes.
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PEG was used. The site of modification was confirmed to be
the N-terminal proline by LC−MS/MS analysis of a tryptic
digest of proline-GFP modified with 2-amino-p-cresol
(Supporting Information Figure S16).
Reaction conditions for both native and proline terminal
proteins were optimized by evaluating reactivity with
myoglobin and proline-GFP. The reaction time, buffer, and
pH were screened (Supporting Information Figures S17 and
S18). Similar to the results obtained with peptide substrates,
the reaction reached its highest level of conversion after about
15−30 min. In addition, most buffer salts tested were
compatible with the reaction with the exception of buffers
containing morpholine (MOPS) or piperazine moieties
(HEPES), as was observed with peptide substrates. These
buffers decreased the level of modification slightly, but did not
completely inhibit reactivity. The effect of reaction pH was
tested using both K3Fe(CN)6 and NaIO4 as the oxidants. Little
reactivity was observed at acidic pH, and the level of conversion
increased between pH 7.0 and 8.0. At higher reaction pH
(≥8.0) a second modification was observed, indicating that
lysines may also participate in the reaction. However, it is also
possible that under more forcing conditions, such as higher
reaction pH or increased concentration of aminophenol
substrate, the aminophenol reacts with both itself and the N-
terminal amino group resulting in double modification of the
N-terminus.
N-terminal mutants of TMV were also evaluated for their
reactivity with o-aminophenols. The TMV monomers assemble
into well-known double disk structures, displaying 34 copies of
the N-terminal groups on their peripheries.60 Two N-terminal
mutants (PAG and AG) were reacted with 5 equiv of 2-amino-
p-cresol (100 μM) and 1 mM K3Fe(CN)6 for 30 min. Analysis
by LC−MS demonstrated that the proline terminal mutant
reached nearly complete conversion, while the alanine terminal
mutant showed low levels of modification under these coupling
conditions (Figure 4b, see Supporting Information Figure S19
for wider mass range and ion series).
The compatibility of the reaction with cysteine residues was
also tested using TMV. A single cysteine residue (S123C) was
introduced into the TMV coat protein with a proline N-
terminus (PAG S123C TMV). This mutant was reacted with 2-
amino-p-cresol and analyzed by LC−MS (Supporting In-
formation Figure S20). The cysteine residue also reacted with
the o-aminophenol, resulting in two modifications.61,62
However, it was found that the N-terminal proline could be
modified selectively if the cysteine was first capped (Figure
5a,b, see Supporting Information Figures S21−22 for wider
mass range and ion series). To do this, the cysteine residue was
protected as a disulfide bond by reaction with 5,5′-dithiobis(2-
nitrobenzoic acid) (DTNB, Ellman’s reagent). After the
oxidative coupling step the disulfide bond was readily reduced
by TCEP, leaving the free cysteine and the modified N-
terminus. Alternatively, the cysteine residue was modified with
a maleimide, followed by modification at the N-terminus with
an o-aminophenol reagent.
This strategy allowed for the direct, dual modification of the
protein at both the cysteine residue and the N-terminus. Two
fluorophores paired for Förster resonance energy transfer
(FRET, Alexa Fluor 488 C5-maleimide and o-aminophenol
functionalized rhodamine B) were thus conjugated to TMV
using this strategy to create a templated array of chromophores
for light harvesting applications.63−65 The free cysteine was first
quantitatively labeled with an Alexa Fluor maleimide
(Supporting Information Figure S22). The N-terminal proline
was then coupled to a fluorescent o-aminophenol resulting in
∼50% modification of the TMV monomers with both
fluorphores (Figure 5b). Complete modification of the N-
terminus was not observed as TMV precipitated from solution
with increasing levels of modification with the rhodamine dye.
In current experiments, we are using this dual-labeling strategy
to introduce more soluble chromophores. We are also
evaluating the energy transfer capabilities of the resulting
systems.65
The oxidative coupling reaction was also compared to the
reaction of protein amines with activated esters. This acylation
methodology is commonly employed, and can be targeted to
the N-terminus by controlling the reaction pH in some cases.66
The reactions were compared on creatine kinase, a protein with
a native proline N-terminus. Reaction with 1−5 equiv of o-
aminophenol PEG resulted in good levels of modification of
creatine kinase (∼50−60%), while reaction with 1−5 equiv of
N-hydroxysuccinimide (NHS) PEG resulted in low levels of
modification (5−25%, Figure 6). Only when a vast excess of the
NHS PEG was used were moderate levels of modification
Figure 4. Effect of N-terminal proline on protein modification. (a) A
proline was introduced to the N-terminus of GFP. Reactivity with o-
aminophenol-PEG was monitored by SDS-PAGE. The proline
terminal variant showed much higher levels of modification than the
wild-type protein. No modification of N-terminal proline-GFP
occurred at pH 6. The band doubling is due to a gel artifact, and
appears in all lanes. (b) Mutants of TMV were reacted with 5 equiv of
2-amino-p-cresol and 1 mM K3Fe(CN)6 for 30 min and analyzed by
LC−MS.
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achieved. As was the case with proline-GFP, some over
modification was observed under the oxidative coupling
conditions when using five or more equivalents of amino-
phenol. This could result from dimerization of the oxidized
species before protein coupling, but has yet to be characterized
due to the low abundance of this product. In any case, lowering
the reaction pH slightly or using fewer equivalents of the o-
aminophenol substrate prevented the over modification from
occurring.
■ CONCLUSION
In this study, we have identified conditions for the oxidative
coupling of o-aminophenols to N-terminal amino acids. Proline
residues work particularly well with this strategy, and are
therefore strongly recommended when using it. These groups
can be introduced readily in N-terminal positions using site-
directed mutagenesis and Escherichia coli expression, especially
since the methionine residue resulting from the start codon is
cleaved when proline is in the second position.67 The fast
kinetics of the reaction allow it to be successful even at low
reagent and substrate concentrations, and suggest that it can be
used for sterically demanding bioconjugations.
The oxidative coupling strategy reported here offers two
distinct advantages over other N-terminal labeling methods.
First, the modification occurs in a single step and does not
require initial oxidation of the N-terminus. Second, the fast
second-order kinetics allow for low concentrations of the
coupling partners to be used. However, to achieve high levels of
modification on protein substrates, proline was required as the
N-terminal residue. Other methods may show a broader scope
for different N-terminal residues.42
This new protein modification strategy is currently being
explored in our lab for the generation of protein-based
materials. In the larger context, new techniques for the
introduction of a single functional group in a specific position
on a protein surface are always in demand. The ability of the N-
terminal oxidative coupling method to achieve this in a single,
brief reaction step is highly advantageous, and the fact that it
can be combined with cysteine modification chemistry provides
new opportunities for complex bioconjugate synthesis.
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Figure 5. N-terminal oxidative coupling for proteins with free cysteines. (a) PAG S123C TMV was reacted with small molecule substrates and
analyzed by LC−MS. Cysteine residues were protected as a disulfide using Ellman’s reagent (DTNB) before oxidative coupling. Subsequent
reduction of the disulfide resulted in selective modification of the N-terminus. (b) PAG S123C TMV was labeled with two fluorophores. The
cysteine was first alkylated with an Alexa Fluor maleimide. The N-terminal proline was then modified with a rhodamine-functionalized o-
aminophenol.
Figure 6. The modification of the N-terminus of creatine kinase with
aminophenol PEG was compared to the reaction of creatine kinase
with NHS PEG. The reactions were analyzed by SDS-PAGE.
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